A new therapy that combines two existing drugs shows promise for patients with inflammatory bowel disease who have exhausted other treatment options, new research finds.
BIOTA Labs, an emerging medical food company revolutionizing medical nutrition for the management of gastrointestinal (GI) ...
For patients with Crohn's disease or ulcerative colitis who have exhausted other treatment options, a new combination therapy ...
An intestinal pathogen reshapes the gut environment to fuel its own colonization and cause diseases, a multi-institutional ...
A stem cell-derived intestine model reveals glycyrrhizin as a potential treatment for inflammatory bowel disease.
Oral presentation on the impact of concomitant steroid use in ulcerative colitis (UC) scheduled for May 5, 2026, at 9:30am CDTAUSTIN, Texas, April 29, 2026 (GLOBE NEWSWIRE) -- Cristcot, a ...
Hosted on MSN
Living well with inflammatory bowel disease
Inflammatory bowel disease (IBD) affects millions, with Crohn’s disease and ulcerative colitis being its main forms. While causes involve complex immune, genetic, and microbial interactions, new ...
Fact checked by Nick Blackmer Digestive issues like bloating and acid reflux are common during perimenopause.Hormonal ...
Autonomix Medical, Inc. (NASDAQ: AMIX) (“Autonomix” or the “Company”), a medical device company dedicated to advancing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results